Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2023 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2023 Earnings Call Transcript August 8, 2023

Seres Therapeutics, Inc. misses on earnings expectations. Reported EPS is $0.36 EPS, expectations were $0.55.

Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Seres Therapeutics’s Second Quarter Earnings Conference Call. [Operator Instructions] I would now like to turn the...